WOMEN 'S HEALTH AND MENOPAUSE : - National Heart, Lung ...

83 Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL,
Spelsberg T. Human giant cell tumors of the bone
(osteoclastomas) are estrogen target cells. Proc
Natl Acad Sci USA 1994;91(12):5227–31.
84 Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T.
Expression of estrogen receptor β in rat bone.
Endocrinology 1997;138(10):4509–12.
85 Arts J, Kuiper GGJM, Janssen JM, et al. Differential
expression of estrogen receptors alpha and beta
mRNA during differentiation of human osteoblast
SV-HFO cells. Endocrinology
1997;138(11):5067–70.
86 Chen MM, Yeh JK, Aloia JF. Effect of ovariectomy
on cancellous bone in the hypophysectomized rat.
J Bone Miner Res 1995;10(9):1334–42.
87 Friend KE, Hartman ML, Pezzoli SS, Clasey JL,
Thorner MO. Both oral and transdermal estrogen
increase growth hormone release in postmenopausal
women–a clinical research center
study. J Clin Endocrin Metab 1996;81(6):2250–6.
88 Sandstedt J, Tornell J, Norjavaara E, Isaksson OG,
Ohlsson C. Elevated levels of growth hormone
increase bone mineral content in normal young
mice, but not in ovariectomized mice.
Endocrinology 1996;137(8):3368–74.
89 Scillitani A, Chiodini I, Carnevale V, et al. Skeletal
involvement in female acromegalic subjects: the
effects of growth hormone excess in amenorrheal
and menstruating patients. J Bone Miner Res
1997;12(10):1729–36.
90 Slootweg MC, Swolin D, Netelenbos JC, Isaksson
OG, Ohlsson C. Estrogen enhances growth hormone
receptor expression and growth hormone
action in rat osteosarcoma cells and human
osteoblast-like cells. J Endocrinol
1997;155(1):159–64.
91 Bryant HU, Glasebrook AL, Yang NN, Sato M. An
estrogen receptor basis for raloxifene action in
bone. J Steroid Biochem Mol Biol 1999;69(1-
6):37–44.
92 Ralston SH, Russell RG, Gowen M. Estrogen inhibits
release of tumor necrosis factor from peripheral
blood mononuclear cells in postmenopausal
women. J Bone Miner Res 1990;5(9):983–8.
98
93 Kimble RB, Srivastava S, Ross FP, Matayoshi A,
Pacifici R. Estrogen deficiency increases the ability
of stromal cells to support murine osteoclastogenesis
via an interleukin-1 and tumor necrosis factormediated
stimulation of macrophage colony-stimulating
factor production. J Biol Chem
1996;271(46):28890–7.
94 Jilka RL. Cytokines, bone remodeling, and estrogen
deficiency: a 1998 update. Bone 1998;23(2):75–81.
95 Spelsberg TC, Subramaniam M, Riggs BL, Khosla S.
The actions and interactions of sex steroids and
growth factors/cytokines on the skeleton. Mol
Endocrinol 1999;13(6):819–28.
96 Hofbauer LC, Khosla S, Dunstan CR, Lacey DL,
Boyle WJ, Riggs BL. The roles of osteoprotegerin
and osteoprotegerin ligand in the paracrine regulation
of bone resorption. J Bone Miner Res
2000;15(1):2–12.
97 Windahl SH, Vidal O, Andersson G, Gustafsson J-Å,
Ohlsson C. Increased cortical bone mineral content
but unchanged trabecular bone mineral density in
female ERbeta(-/-) mice. J Clin Invest
1999;104(7):895–901.
98 Lee PA, Witchel SF. The influence of estrogen on
growth. Curr Opin Pediatr 1997;9(4):431–6.
99 Klein KO, Martha PM Jr, Blizzard RM, Herbst T,
Rogol AD. A longitudinal assessment of hormonal
and physical alterations during normal puberty in
boys. II. Estrogen levels as determined by an
ultrasensitive bioassay. J Clin Endocrinol Metab
1996;81(9):3203–7.
100 Grodstein F, Stampfer MJ, Colditz GA, et al.
Postmenopausal hormone therapy and mortality.
N Engl J Med 1997;336(25):1769–75.
101 Nathan L, Chaudhuri G. Estrogens and atherosclerosis.
Annu Rev Pharmacol Toxicol
1997;37:477–515.
102 Mendelsohn ME, Karas RH. The protective effects
of estrogen on the cardiovascular system. N Engl J
Med 1999;340(23):1801–11.
103 Hulley S, Grady D, Bush T, et al. Randomized trial
of estrogen plus progestin for secondary prevention
of coronary heart disease in postmenopausal
women. Heart and Estrogen/progestin Replacement
Study (HERS) Research Group. JAMA
1998;280(7):605–13.